This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Wealth planning tools are essential for financial success. Discover resources that can help you achieve your financial aspirations.
28,655 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
When a senior executive at Maze Therapeutics sells a stake after positive trial data and solid quarterly results, inv...
In this stock market today update, Intel pulls back as AI bubble risk concerns rise, even as AI-driven momentum suppo...
Disney escalates a high-stakes clash with the FCC as ABC stations face early license reviews. A $15 million payment t...
The House Ways and Means Committee plans a June hearing to decide if crypto tax relief should cover more than stablec...
In this morning minute, crypto markets buckled as hawkish Fed signals raised rate hike odds. We unpack the drivers, s...
Qualcomm rolls out a five year plan to compete with Nvidia in AI data center chips, aiming for multi billion dollar A...
July began with AI-driven headlines shifting attention from headlines to execution. This guide breaks down how stock ...
When a Fed chair speaks about prices being too high, markets hear implications for rates. This article unpacks what t...
A prominent investment firm just showed its hand in energy delivery by buying a large stake in Chesapeake Utilities. ...
Nio stunned investors with its first quarterly net profit, driving a sharp rally on a market day shaped by mixed indi...
The Trade Desk slid again amid reports of agency cautions and analyst downgrades. This piece explains the drivers, wh...